(NYSE: AVNT) Avient's forecast annual revenue growth rate of 2.86% is not forecast to beat the US Specialty Chemicals industry's average forecast revenue growth rate of 13.5%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 12.7%.
Avient's revenue in 2026 is $3,416,200,000.On average, 12 Wall Street analysts forecast AVNT's revenue for 2026 to be $319,917,730,132, with the lowest AVNT revenue forecast at $305,146,650,536, and the highest AVNT revenue forecast at $331,569,451,304. On average, 12 Wall Street analysts forecast AVNT's revenue for 2027 to be $330,560,247,108, with the lowest AVNT revenue forecast at $310,284,417,352, and the highest AVNT revenue forecast at $345,514,818,376.
In 2028, AVNT is forecast to generate $344,689,105,852 in revenue, with the lowest revenue forecast at $327,624,380,356 and the highest revenue forecast at $362,763,035,544.